Integration of CT urography improves diagnostic confidence of 68Ga-PSMA-11 PET/CT in prostate cancer patients

被引:0
作者
Leon Will
Frederik L. Giesel
Martin T. Freitag
Anne K. Berger
Walter Mier
Klaus Kopka
Stefan A. Koerber
Hendrik Rathke
Christophe Kremer
Clemens Kratochwil
Hans-Ulrich Kauczor
Uwe Haberkorn
Tim F. Weber
机构
[1] Heidelberg University Hospital,Department of Nuclear Medicine
[2] Cooperation Unit Nuclear Medicine,Department of Medical Oncology, National Center for Tumor Diseases
[3] German Cancer Research Center (dkfz),Department of Radiation Oncology
[4] Division of Radiology,Department of Diagnostic and Interventional Radiology
[5] German Cancer Research Center (dkfz),undefined
[6] Heidelberg University Hospital,undefined
[7] Division of Radiopharmaceutical Chemistry,undefined
[8] German Cancer Research Center (dkfz),undefined
[9] Heidelberg University Hospital,undefined
[10] Heidelberg University Hospital,undefined
来源
Cancer Imaging | / 17卷
关键词
PSMA; Pet/Ct; CT urography; Prostate cancer; Renal excretion; Staging;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 208 条
[21]  
Walsh PC(2012)Urography with synchronous nephrographic and excretory phase enhancement Eur J Radiol 81 e830-577
[22]  
Kosuri S(2015)Reducing radiation in CT urography for hematuria: effect of using 100 kilovoltage protocol AJR Am J Roentgenol 205 572-4353
[23]  
Akhtar NH(2016)Of radiation doses in CT urography before and after implementation of iterative reconstruction Eur Radiol 26 4345-574
[24]  
Smith M(2015)68Ga-PSMA I&T PET/CT for assessment of prostate cancer: evaluation of image quality after forced diuresis and delayed imaging Mol Imaging Biol 17 565-20
[25]  
Osborne JR(2014)Initial evaluation of [(18)F]DCFPyL for prostate-specific membrane antigen (PSMA)-targeted PET imaging of prostate cancer Eur J Nucl Med Mol Imaging 41 11-1891
[26]  
Tagawa ST(2012)Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer J Nucl Med 53 1883-1705
[27]  
Afshar-Oromieh A(2015)Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer J Nucl Med 56 1697-undefined
[28]  
Babich JW(undefined)The Theranostic PSMA ligand PSMA-617 in the diagnosis of prostate cancer by PET/CT: biodistribution in humans, radiation dosimetry, and first evaluation of tumor lesions undefined undefined undefined-undefined
[29]  
Kratochwil C(undefined)undefined undefined undefined undefined-undefined
[30]  
Giesel FL(undefined)undefined undefined undefined undefined-undefined